Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum

Br J Dermatol. 2022 Aug;187(2):138-139. doi: 10.1111/bjd.21591. Epub 2022 May 9.

Authors

Christina H Scheel¹, Nessr Abu Rached¹, Thilo Gambichler¹

Affiliation

¹ Skin Cancer Center, Department of Dermatology, Ruhr-University, 44801 Bochum, Germany.

PMID: 35531874
DOI: 10.1111/bjd.21591

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Hidradenitis Suppurativa*
Humans
Interleukins
Skin / metabolism

Substances

Antibodies, Monoclonal, Humanized
Interleukins
brodalumab